Navigation Links
A product for the detection and characterization of brucellosis launched at University of Navarra
Date:3/26/2008

This release is available in Spanish.

Ignacio Lpez-Goi and David Garca, researchers of the Department of Microbiology and Parasitology of the University of Navarra, have launched a new product for the detection and characterization of the Brucella bacteria, which is the causative agent for brucellosis, also known as Mediterranean fever. Their product is a commercial analysis kit, sold under the brand name Bruce-ladder, and was developed in collaboration with Ingenasa, a Madrid-based business dedicated to applied biotechnology in the areas of animal and human health and food safety.

Bruce-ladder permits the identification and differentiation of the microorganism via the amplification of sequences of specific genes using the PCR (polymerase chain reaction) technique. In order to develop this product, these microbiologists of the School of Sciences analyzed the complete sequences of the genomes of various distinct species of Brucella, which permitted them to design a system capable of differentiating them in a single test, and in less than 24 hours.

The novelty of this techniques derives from the fact that is able to distinguish all the known species of Brucella, including vaccine lines and the isolated species present in marine mammals.

A more rapid and safe analysis

"Up to now, differentiation of Brucella was only performed in central laboratories, by means of complicated biochemical and serological techniques, handling the bacteria themselves, which involved a risk for the laboratory personnel. Now, with this new molecular test, the bacteria samples can be analyzed in a simpler and more rapid manner, without having to handle the bacteria directly", as the microbiologists of the University of Navarra explained. The kit has been tested by various leading laboratories in France, Belgium and Portugal, and has been approved by the National Brucellosis Reference Center, in Granada.

Brucellosis is an infectious disease which affects both livestock and persons. According to the World Health Organization, brucellosis is part of a group of diseases, which also includes rabies and anthrax, which are considered forgotten diseases, and are strongly related to poverty. The incidence of brucellosis is very high in Africa, Asia, the Middle East and Latin America, and it is a factor in the lack of economic progress and development in these areas of the world. This new kit will aid in its diagnosis, and will permit epidemiological studies which will help to control and eventually eradicate the disease.


'/>"/>

Contact: Garazi Andonegi
garazi@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
Source:Eurekalert

Related medicine news :

1. London Luxury Receives Asthma & Allergy Friendly(TM) Certification for Several of Its Bedding Products
2. Jopari Ramps Up Texas eBill Production With National and Regional Carriers and Medical Billing Technology Suppliers
3. NY-Area Paramedic Wins 2007 Francis X. Hursey Award for Heroic Use of QuikClot(R) Blood Clotting Product
4. Blue Cross Blue Shield of Michigan Pioneers Total Body PPO Product
5. Scripps Florida scientists develop a process to disrupt hepatitis C virion production
6. Mirion Technologies to Showcase New Product Offerings for the Nuclear Industry During 10th Annual China International Nuclear Industry Exhibition
7. National Religious Coalition Deeply Concerned by HHS Secretarys Disregard for Womens Reproductive Health
8. Schiff(R) Introduces New Supplement Products for Intestinal Health and Beauty Maintenance
9. Do bacterial combinations result in enhanced cytokine production? No!
10. Leading Health Groups Applaud Continued Efforts to Protect Public Health by Ending So-Called Theatrical Productions in Bars
11. Sergeants(R) Pet Care Products Acquires the Consumer Brand Division of Virbac Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... San Diego, CA (PRWEB) , ... June 24, 2016 , ... ... up with the American Cancer Society and the Road To Recovery® program to drive ... care to seniors and other adults to ensure the highest quality of life and ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, ... economy by obtaining investment capital for emerging technology companies. SCP has delivered ... already resulted in more than a million dollars of capital investment for five ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... for human induced pluripotent stem (iPS) cells and other difficult to transfect cells, ... Cloning Medium. The PluriQ™ G9™ Gene Editing System is a complete ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
Breaking Medicine Technology: